Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| George Kemble | M | 63 | 13 years | |
| Merdad Parsey | M | 61 | 14 years | |
| Tassos Gianakakos | M | 51 | 11 years | |
| David J. Teece | M | 75 |
University of California, Berkeley
| 42 years |
| Bruce B. Darling | M | 71 |
University of California, Berkeley
| 44 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Swisher | M | 61 | 16 years | |
| John Curnutte | M | 72 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| G. Kirk Raab | M | 88 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
| Qing Huang | M | 62 |
University of California, Berkeley
| 6 years |
| Irving Mintzer | M | - |
University of California, Berkeley
| 13 years |
| Sung Su Han | M | 72 |
University of California, Berkeley
| 12 years |
| Ingrid Boyes | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
| David Stump | M | 74 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 26 years |
| Eric Bjerkholt | M | 64 | 13 years | |
| Carl Perez | M | - |
University of California, Berkeley
| 8 years |
| Steven Ketchum | M | 59 | 13 years | |
| Kamal H. Khayat | M | - |
University of California, Berkeley
| 7 years |
| Thomas E. Bell | M | 75 |
University of California, Berkeley
| 4 years |
| Vishva Dixit | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Jackie W. Hoffmann | F | - |
University of California, Berkeley
| 6 years |
| Stanton D. Wong | M | - |
University of California, Berkeley
| 3 years |
| Ray Salomon | M | 61 |
University of California, Berkeley
| 7 years |
| Stephen Brady | M | 54 | 3 years | |
| Andreas C. Cangellaris | M | - |
University of California, Berkeley
| 3 years |
| Valerie Pierce | F | 61 | 2 years | |
| Bahram Nour-Omid | M | - |
University of California, Berkeley
| 4 years |
| Pierre Breber | M | 59 |
University of California, Berkeley
| 5 years |
| Peter Carson | M | - |
University of California, Berkeley
| 8 years |
| Michael J. Estrada | M | - |
University of California, Berkeley
| 3 years |
| Ori Sasson | M | - |
University of California, Berkeley
| 6 years |
| Sean W. O'Dea | M | - | 2 years | |
| Steven Chan | M | 52 | 3 years | |
| Denelle Waynick | F | 57 | - | |
| Adam Rossman | M | 57 |
University of California, Berkeley
| 6 years |
| Nat Simons | M | - |
University of California, Berkeley
| 10 years |
| Wai Cheung Tong | M | 70 |
University of California, Berkeley
| 3 years |
| Joel Caldwell | M | 69 |
University of California, Berkeley
| 6 years |
| June Lee | M | 58 | 3 years | |
| Marty Monserez | M | - |
Butler University
| 6 years |
| Steven Lo | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
| Michelle Corral | F | - | 4 years | |
| Wei-Tek Tsai | M | 64 |
University of California, Berkeley
| 5 years |
| Jerry Cacia | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 28 years |
| Sunil Agarwal | M | 54 | 4 years | |
| Tami S. Smason | F | - |
University of California, Berkeley
| 8 years |
| David Meeker | M | 69 | 3 years | |
| Richard G. Wallace | M | - |
University of California, Berkeley
| 7 years |
| Sosale Shankara Sastry | M | 68 |
University of California, Berkeley
| 3 years |
| Larry Nan-lei Wang | M | - |
University of California, Berkeley
| 4 years |
| Daryl B. Winter | M | 80 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 18 years |
| James W. Young | M | 79 | 21 years | |
| Homer Pearce | M | 71 | 15 years | |
| Kevin Starr | M | 61 | 6 years | |
| Gordon Ringold | M | 73 | 14 years | |
| Eric Topol | M | 69 | 2 years | |
| Charles Homcy | M | 75 | 5 years | |
| Arthur Levinson | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 19 years |
| Mark Perry | M | 68 | 8 years | |
| Paul Hastings | M | 64 |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | 2 years |
| James Young | M | 71 | 13 years | |
| Daniel Petree | M | 68 |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | 6 years |
| James Hildebrand Roberts | M | 67 |
University of California, Berkeley
| 5 years |
| Peter Y. Tam | M | 60 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
University of California, Berkeley
| 7 years |
| John M. Whiting | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 20 years |
| Fu Chieh Hsu | M | - |
University of California, Berkeley
| 3 years |
| Mary Cranston | F | 76 | 4 years | |
| Wendy Yarno | F | 69 | 3 years | |
| Cynthia J. Ladd | F | 68 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 15 years |
| Eric Stonestrom | M | 62 |
University of California, Berkeley
| 6 years |
| Daniel Adelman | M | 66 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
| Gregory M. Heywood | M | 59 |
University of California, Berkeley
| 12 years |
| Steve Tighe | M | - |
University of California, Berkeley
| 5 years |
| Steven Shak | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| Kim Popovits | F | 65 | 3 years | |
| Michael Cima | M | 64 |
University of California, Berkeley
| 8 years |
| Matthew Fust | M | 59 | 12 years | |
| Lisa Suennen | F | 58 |
University of California, Berkeley
| 5 years |
| Annette C. North | F | 58 |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | 1 years |
| Sarah Hymowitz | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 22 years |
| David Nagler | M | 71 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| James A. Wells | M | 73 | 10 years | |
| Weijian Shan | M | 70 |
University of California, Berkeley
| 4 years |
| Jay Wintrob | M | 67 |
University of California, Berkeley
| 7 years |
| Paul Ernest Johnson | M | 62 |
University of California, Berkeley
| 5 years |
| Richard D. Byrd | M | - |
University of California, Berkeley
| 4 years |
| Kevin S. Masuda | M | - |
University of California, Berkeley
| 4 years |
| David Hanzel | M | - |
University of California, Berkeley
| 6 years |
| Eddie Hurip | M | 66 |
University of California, Berkeley
| 4 years |
| Mark Lee | M | 64 |
University of California, Berkeley
| 4 years |
| Dave Butler | M | - |
University of California, Berkeley
| 4 years |
| Hsien Chieng Hsia | M | 60 |
University of California, Berkeley
| 4 years |
| Adam Markman | M | 59 |
University of California, Berkeley
| 4 years |
| Marcia DeForest | F | - |
University of California, Berkeley
| 2 years |
| Michael J. Kaufman | M | 66 |
University of California, Berkeley
| 4 years |
| Kent Edwin Stone | M | 60 |
University of California, Berkeley
| 4 years |
| Adya S. Tripathi | M | - |
University of California, Berkeley
| 3 years |
| Mao Chun Hsu | M | 59 |
University of California, Berkeley
| 4 years |
| Peter H. Fisher | M | - |
University of California, Berkeley
| 4 years |
| Bing Qiang Gao | M | 73 |
University of California, Berkeley
| 3 years |
| Michael Christopher Hart | M | 57 |
University of California, Berkeley
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert McDowell
- Personal Network
